Ornithine transcarbamylase (ornithine carbamoyltransferase; carbamoyl-phosphate:L-ornithine carbamoyltransferase, EC 2.1.3.3) is a mitochondrial matrix enzyme of the mammalian urea cycle. The X chromosome-linked spf ah mutation in the mouse causes partial ornithine transcarbamylase deficiency and has served as a model for the human disease. We show here that the spf h mutation is a guanine to adenine transition of the last nucleotide of the fourth exon of the ornithine transcarbamylase gene. This nucleotide change produces two remarkably different effects. First, this transition causes ornithine transcarbamylase mRNA deficiency because the involved exon nucleotide plays a part in the recognition of the adjacent splice donor site. As a result of the mutation, ornithine transcarbamylase pre-mRNA is spliced inefficiently both at this site and at a cryptic splice donor site 48 bases into the adjacent intron. Second, two mutant proteins are translated from these mRNAs. From the correctly spliced mRNA, the transition results in a change of amino acid 129 from arginine to histidine. This missense substitution has no discernable effect on mitochondrial import, subunit assembly, or enzyme activity. On the other hand, the elongated mRNA resulting from mis-splicing is translated into a dysfunctional ornithine transcarbamylase subunit elongated by the insertion of 16 amino acid residues.
Ornithine transcarbamylase (ornithine carbamoyltransferase; OTCase; carbamoyl-phosphate:L-ornithine carbamoyltransferase, EC 2.1.3.3) is a mitochondrial matrix enzyme of the mammalian urea cycle. In both humans and mice, the OTCase gene is located on the X chromosome and is composed of 10 exons spread over 70-80 kilobase pairs (kbp) (1, 2) . The gene is expressed primarily in the liver and directs the formation of a 40-kDa precursor protein (pOTCase). The pOTCase is imported into the mitochondrial matrix and cleaved of its N-terminal leader peptide, and the 36-kDa mature subunits assemble into an enzymatically active homotrimer.
In humans, hereditary OTCase deficiency is an X chromosome-linked disorder often leading to lethal neonatal hyperammonemia (3) . Two mouse strains with partial OTCase deficiency serve as useful animal models: sparse fur (spf) (4); and sparse fur-abnormal skin and hair (spfash) (5) . These mice have permitted the study of various clinical aspects of OTCase deficiency (6); they also have served as experimental targets for gene therapy (7) . The spf mouse phenotype is caused by a missense mutation, changing histidine to asparagine at amino acid 117 (8) . Although OTCase is produced in normal amounts, the mutation impairs enzymatic activity (9) (10) (11) .
The spfash mutation has a unique effect on OTCase biogenesis (12, 13) . From the single mutant gene in males, two OTCase precursors are produced, which together amount to only 10% of wild-type pOTCase levels. One pOTCase is normal in all characteristics of its structure and biogenesis except quantity and gives rise to the residual (5-10%) hepatic OTCase activity in the spfash mice. The other pOTCase is elongated, based on its apparent molecular weight. It is capable of uptake into mitochondria, where it is cleaved to an elongated mature subunit. It cannot assemble into an active trimeric structure, however, and appears to degrade rapidly within the mitochondrion without contributing to the detectable steady-state protein level or enzymatic activity. To answer the question of how one mutant OTCase gene produces two discrete translation products, we have studied the structure of the OTCase gene and its transcripts in spfash male mice and normal male littermates.
MATERIALS AND METHODS
Animals and Biological Samples. A colony of spf ash mice has been maintained at the Yale School of Medicine from breeding pairs kindly provided by Donald Doolittle. All animals used for this study were male mice, either spfash hemizygotes or normal littermates. The genotype was assessed by the phenotypic appearance of the animals at about 1 week of age and was confirmed in every case by assay of hepatic OTCase enzyme activity (12) . Hepatic mRNA was isolated (14) and enriched for polyadenylylated mRNA (15) . RNA was separated on a 1.75% agarose gel in formaldehyde, transferred to nitrocellulose, and probed (15) first with a rat OTCase cDNA (16) and then with a mouse serum albumin cDNA isolated in this laboratory (P.E.H., unpublished data). Genomic DNA was prepared from brain (15) .
Isolation of a Wild-Type Mouse OTCase cDNA. A cDNA library from wild-type mouse liver mRNA was prepared exactly as described for the rat (16) . A partial 3' OTCase cDNA was isolated from it by hybridization to a rat OTCase cDNA (16 30 min at 37°C with a range of concentrations of S1 nuclease from 33 units/ml to 3300 units/ml (18) . A single S1 nuclease concentration from each titration is shown in Fig.  2 (Lower) (A, 900 units/ml; B, 600 units/ml; C and D, 250 units/ml; E, 750 units/ml). Protected fragments were visualized by autoradiography after electrophoresis through 8 M urea/6% polyacrylamide gels.
Polymerase Chain Reaction (PCR) Amplification and Cloning. We performed PCR amplification (19) using Thermus aquaticus DNA polymerase (New England Biolabs) and the reagent concentrations recommended by the supplier. The cDNAs to be amplified (100 ng per 100 ,ul of reaction mixture), either double stranded or first stranded only, were prepared as described (16, 20) .
The amplification primers were M2 (5'-GCCATGGTGTC-CAGATCTGA) and M3 (5'-ATTGCAAGGGAAATCClTA-GGAATG). After initial denaturation at 98°C for 7 min, the 40 amplification cycles were at 90°C for 30 sec, 37°C for 30 sec, and 63°C for 90 sec; the final polymerization was extended for 15 min. Samples were desalted by Centricon centrifugal filtration (Amicon), digested with appropriate restriction enzymes, and ligated into similarly digested plasmid vectors, either pGEM-3Z (Promega) or the wild-type mouse OTCase cDNA plasmid, replacing the analogous region of spMO-3. In this way, spAMO-PM (containing the spf ash mouse point-mutated OTCase cDNA) and spAMO-E (containing the spfash mouse elongated OTCase cDNA) were created.
PCR amplification of genomic DNA (1 ,ug, intact) was performed under identical conditions, using oligonucleotide primers M10 (5'-ATTTGGTTAACATTTlAGTT) and M11 (5'-GGCATTATCTAAGGAGAAGC). Products were ligated directly into HincII-digested pGEM-3Z (Promega). Sequences of PCR-derived clones were determined by dideoxynucleotide sequencing as described above.
In Vitro Reconstruction of OTCase Biogenesis. The methods for in vitro SP6 RNA polymerase transcription, in vitro translation, immune precipitation, isolation of rat liver mitochondria, in vitro mitochondrial uptake, assay for OTCase assembly using N8-phosphonoacetyl-L-ornithinyl-Sepharose chromatography, and polyacrylamide gel electrophoresis have been described elsewhere (21, 22) . To assay for intramitochondrial stability of newly imported OTCase polypeptides, samples containing translation mixtures and intact mitochondria were first incubated at the usual temperature (27°C) for 1 hr. The incubation temperature was then raised to 37°C, and serial samples were removed for an additional 8 hr.
RESULTS
Isolation of a Normal Mouse OTCase cDNA and RNA Blot Analysis of mRNA. For comparison with the structure of the spf ash mouse OTCase mRNA, we isolated and analyzed cDNA clones encoding wild-type mouse OTCase. RNA blot analysis ( Fig. 1) showed that hepatic OTCase mRNA from normal and spfash mice is =1700 nucleotides long and is heterogenous in size [due perhaps to multiple transcription initiation sites (8) ]. Total spf sh OTCase mRNA is reduced to l10o of control levels, consistent with estimations from in vitro translation (12) and results reported by others (23) . No mRNA of abnormal size is detectable in spfash mouse liver, but these blots would not have resolved the small size difference corresponding to the observed elongation in the spfash pOTCase protein.
S1 Nuclease Protection Assays. We modified S1 nuclease protection assays specifically to detect small RNA insertions relative to the DNA probes. This detection involved nuclease "cut through" (24) (25) (26) , digesting not only the single-stranded RNA loop but also cutting the probe at the site in the duplex opposite the resulting nick. Using titration of S1 nuclease to high enzyme concentrations and higher than usual temperatures, we were able to obtain uniform cleavage of the probe strand opposite as little as a 12-base RNA insertion (data not shown). S1 nuclease protection experiments were carried out with wild-type and spf ash male liver poly(A)+ mRNA. Using 10 times the amount of RNA from the mutant mice, equal protection levels of the probes were obtained. The coding sequence of the OTCase cDNA was analyzed in four sections, using four end-labeled cDNA probes A, B, C, and D (Fig. 2) . Probes A, C, and D were protected identically by normal and mutant mRNA. This protection extended over the entire length of the OTCase cDNA sequences, while residual plasmid sequences were accurately cleaved from probe A. No internal cleavages were detected with these probes; i.e., no shorter fragments of the probe were created by S1 nuclease digestion. Probe B, however, was cleaved by S1 nuclease internally when protected by spfash mRNA (Fig.  2 Lower, B, arrowhead). Only a portion of the spfash mRNA-cDNA hybrids allowed internal S1 nuclease cleavage. Most of the hybrids were protected along their entire length. This implied that there were two OTCase mRNA species in the spfash mice, one apparently normal in structure, and one with a detectable internal difference.
To confirm this result, and to show that this detected difference was not an mRNA truncation or a deletion, probe E was prepared. This probe covered the same cDNA region but was end-labeled on the opposite end of the probe strand as probe B. Probe E was also cleaved internally ( Fig. 2 Lower, E, arrowhead). Furthermore, the sites of cleavage of probes B and E, deduced from the sizes of the cleavage products, mapped to the same site (Fig. 2 Upper, x). These results were consistent with an RNA insertion, a very small wt w spfash 10 10 OTC (<10 bases) deletion, or a detectable point mutation, in some but not all of the Spfash OTCase mRNA. This region of interest maps to the site of splicing of exon 4 to exon 5 (2). PCR Amplification and cDNA Cloning. To characterize further the splice junction between exons 4 and 5 in the Spfash cDNA, we amplified this region by the PCR (19) . Using oligonucleotide primers complementary to sequences in exons 3 and 5, cDNA from normal or spfash mRNA was subjected to 40 cycles of amplification. Aliquots of the products were separated by denaturing polyacrylamide gels, transferred to a nylon membrane, and hybridized to a radiolabeled normal mouse OTCase cDNA fragment. As shown in Fig. 3 , normal mouse cDNA produced a single prominent amplification product of the expected size (228 bp). Two major amplification products were produced from spfash mouse cDNA, however: one of normal size and one elongated. The nucleotide sequence of clones derived from the amplified normal mouse cDNA agreed exactly with previously isolated cDNAs (Fig. 4) .
Nucleotide sequencing of the normal length product from spfash cDNA showed an unexpected nucleotide change. The last nucleotide of exon 4 was A instead of G (Fig. 4) . This change was seen in each of six independent clones from the spfash cDNA, produced from two independent PCR amplifications, as well as in the direct sequencing of the gelpurified normal length amplified cDNA. This nucleotide transition predicts that the normal-sized pOTCase protein in spfash mice contains an amino acid substitution of histidine for arginine at amino acid 129.
The nucleotide sequence of the longer cDNA from the spfash mouse was even more interesting (Fig. 4) . This cDNA contained the G to A transition discussed above, followed immediately by a 48-bp insertion. The sequence of this insertion agreed completely with the published sequence of the 5' end of intron 4 (2). The following six nucleotides in the genomic sequence (2) are a good match to the consensus sequence (27, 28) for a splice donor site (Fig. 4 Lower, cryptic site). Thus, a cryptic splice donor site 48 bases into intron 4 is used to create the elongated mRNA and from it, the elongated pOTCase.
Genomic DNA Clones. We generated and analyzed genomic DNA clones from wild-type and spfash mouse OTCase genes to show that the point mutation was specific for the spfash mutation and to exclude the possibility that two nucleotide differences were present to produce the spfash phenotypee.g., that the G to A transition decreased use of the normal splice site and that a second mutation within the intron activated the cryptic site. Oligonucleotide primers for PCR were prepared based on the published sequence of introns 3 and 4 (2). These primers flank exon 4 such that a 250-bp DNA fragment would result from amplification. Products of PCR amplification of genomic DNA from an spf ash male and a wild-type male littermate were cloned and sequenced. The sequences of these DNAs agreed with those published (2) , with the exception of the same G to A transition in the genomic DNA of the spf ash mouse. Specifically, no other mutations were found surrounding the activated cryptic site, which was identical in normal and spfash DNAs.
Biogenesis of OTCase in Vitro. We next proved that the two types Of spfash mRNA were sufficient to account for the OTCase proteins translated by mutant liver mRNA. We substituted the PCR-amplified cDNAs, as restriction fragments, for the analogous region of the normal mouse cDNA in a transcription vector. These cDNAs were transcribed in vitro, and the mRNA generated was translated in vitro as a reticulocyte lysate. As shown in Fig. 5 ACC GCT CAG TTT GTA AAA CTT TTC TTC CTT CCA AAG TTT ATT TCA AAC TCT GAT GG  NT GTC (27) is compared to the wild-type OTCase exon 4 donor site, the mutated donor site, and the cryptic site within intron 4, which is used to create the elongated cDNA. The A resulting from the spf ash mutation is shown in boldface type.
Mixing of the translation products of the point mutation mRNA and the elongated mRNA reproduced the pattern of pOTCase translation from spfash liver mRNA.
Furthermore, in experiments not shown, when the Spfash OTCase precursors were incubated with isolated rat liver mitochondria, both pOTCase proteins were imported and cleaved to mature subunits. After the mitochondria had been solubilized, the newly formed OTCase subunits were assayed for assembly. A portion of the wild-type OTCase and the missense substituted OTCase bound to a 8-N-phosphonoacetyl-L-ornithine affinity column, indicating that the newly formed mature subunits had assembled into an active trimer. None of the elongated subunits bound to the affinity ligand, however, confirming the observations of Rosenberg et al. (12) . To determine more specifically the fate of the elongated OTCase subunits, mitochondria were incubated for additional times at 37°C. use of the adjacent splice donor site. The splice site is used to produce only 5% of wild-type levels of properly spliced mRNA. An additional mRNA, using a cryptic splice donor within intron 4, is also produced at 5% of wild-type levels. Apparently, 90% of the pre-mRNA transcripts are degraded, either after unproductive mis-splicing or without removal of intron 4 . Second, translation of the mRNAs produces two pOTCase proteins. One contains a missense mutation, changing arginine 129 to histidine. This substitution, however, does not inhibit mitochondrial import or assembly of the precursor, nor does it have any detectable effect on the enzyme's activity. The second precursor contains an insertion of 16 amino acids encoded by 48 bases of intron 4. The internal insertion does not affect mitochondrial import but apparently prevents proper folding or subunit trimerization so that the unassembled elongated subunits are degraded rapidly within mitochondria.
Effects of an Exon Nucleotide on an Adjacent Splice Site. The spfash mutation shows unusually drastic effects of a nucleotide change within an exon on the use of an adjacent splice donor site. It has been recognized that the conserved sequences of the consensus splice sites extend to the adjacent exon nucleotides (27, 28) . Nevertheless, there are few examples of naturally occurring mutations within the exon portions of splice sites that affect mRNA splicing. The only natural precedent for the spfash mutation is the ry5208 mutation at the rosy (xanthine dehydrogenase) locus ofDrosophila melanogaster, which changes the last nucleotide of the first exon from G to A (29) . Although enzyme production from this allele is negligible, the effect of the mutation on pre-mRNA splicing has not been reported. A mutation identical to the spfash mutation has been created in rabbit,8-globin exon 2 by DNA manipulation. This G to A change had no effect on mRNA splicing in vivo (30) . In an in vitro splicing extract, the mutation had a modest effect, still allowing correct splicing at >50%o of wild-type efficiency (31) .
The most obvious resolution ofthe dichotomy between the drastic effects of the spf ash mutation and the innocuous effects of the same mutation at the globin locus is that the spf ash mutation occurs adjacent to a 5' splice site, which already is only a poor match to the consensus sequence (Fig.  4) . In fact, the wild-type donor site matches the 5' splice site consensus only as well as the worst four matches reported by Mount (27) . None of the naturally occurring donor sites reported matched as poorly as the spf ash site. We have also detected, at low levels, mis-splicing of the normal OTCase gene, so as to join exon 3 to exon 5 (unpublished data). This may be a consequence of the inefficient use of the wild-type splice donor site of exon 4. The Spf ash mutation apparently converts a poor but functional site into a barely usable site. (32) . In contrast, it is easy to imagine how the insertion of the 16-amino acid peptide encoded by the intron sequence might prevent the assembly of OTCase, especially because the inserted peptide is rich in bulky and hydrophobic amino acids. Its effect in this regard has been demonstrated by the in vitro reconstruction of OTCase biogenesis. The elongated pOTCase is imported into mitochondria normally, and its mitochondrial leader peptide is accurately removed by proteolytic cleavage. The elongated OTCase subunit, however, does not adopt the trimeric conformation necessary to bind to a substrate affinity column. Furthermore, this elongated OTCase is selectively degraded.
